Abstract
BackgroundUp to one third of spondylarthritis (SpA) fail to respond to anti-TNF agents or experience drug toxicity leading to treatment withdrawal. Part of the treatment failure can be explained by...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
